| Tuesday, April 7, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8:30 AM - 9:00 AM | Breakfast and Networking | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9:00 AM - 9:10 AM | Welcome & Opening Remarks  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9:10 AM - 9:30 AM | Keynote Address: Federal Health Policy Priorities and the Commercial Market  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9:30 AM - 10:20 AM | Hospital Prices Under the Microscope: Transparency and Accountability      Hospital prices remain the largest driver of employer healthcare costs. This discussion will explore how transparency policies are shaping the market and what reforms may come next. Bret Jackson, President and CEO, Economic Alliance for Michigan Mark E Miller, Executive Vice President of Health Care, Arnold Ventures Christine Monahan, JD, Assistant Research Professor Center on Health Insurance Reforms, Georgetown University McCourt School of Public Policy James Startare, Vice President, Benefits, Aramark Una Lee, Chief Counsel, Democratic Staff – House Energy and Commerce Committee, U.S. House of Representatives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:20 AM - 10:35 AM | Networking Break | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:35 AM - 11:15 AM | PBM Reform Is Here: What Employers Need to Know Next     With new federal reforms poised to reshape the PBM market, experts discuss what the changes mean for employer health plans and what steps employers and policymakers should be considering next, including broader uptake of biosimilars and other high-value medications. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:15 AM - 11:55 AM | 340B at a Crossroads: Transparency, Growth, and the Impact on Employers    As the 340B program continues to expand, policymakers and employers are raising new questions about transparency, oversight, and how the program affects the commercial healthcare market. Panelists will discuss the new 340B rebate model and federal reform efforts. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:55 AM - 12:00 PM | Closing Remarks and Call to Action | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||